Financing channel feed – Endpoints News

Financing channel feed

Exclusive: British startup raises $16M to find genes that rewind the epigenetic clock

7 months ago

VC firm targets $35M second fund to back startups led by scientists

7 months ago

Biotech startups Upstream and CAMP4 price Friday IPOs

7 months ago

Immatics heads to Phase 3 with melanoma cell therapy, seeks to raise $150M

7 months ago

Exclusive: Reema Health raises $7.6M to reach people on Medicaid

7 months ago

Gritstone files for bankruptcy, says it could forge a transaction as early as this month to keep R&D going

7 months ago

Basecamp raises $60M to travel the globe and fill AI data gaps, signs deal with David Liu

7 months ago

Purespring nabs $105M to take gene therapy into the clinic as IgAN field matures

7 months ago

John Maraganore's RNAi biotech City Therapeutics debuts with $135M Series A

7 months ago

Exclusive: A small San Diego biotech wants to change how Parkinson’s disease is diagnosed

7 months ago

Orasis snags $78M to launch presbyopia eye drops more than a year after FDA approval

7 months ago

Exclusive: Lilly backs a16z-funded Arda Therapeutics' $43M Series A to take ADCs into fibrosis

7 months ago

Exclusive: Tiny startup with big vision to extend healthspan by 20 years says it discovered an ‘Atlas of Rejuvenation’

7 months ago

Oaktree creates third life sciences SPAC, following success with Hims & Hers and Alvotech

7 months ago

Upstream and CAMP4 target $182M, $67M IPOs

7 months ago

Biotech's third quarter was relatively bright — with a few caveats

7 months ago

Flagship partners with key Singapore R&D agency as it boosts APAC investment

7 months ago

Enara Bio’s $32.5M Series B to support lead dark antigen program for GI cancers

7 months ago

Investor Kurma Partners raises €140M for latest Europe-focused biotech fund

7 months ago

Resolution raises $85M to test macrophage therapies in end-stage liver disease

7 months ago

Septerna files for Nasdaq listing as biotech IPOs come to life

7 months ago

Frazier adds $630M to public fund to 'take advantage of market volatility'

7 months ago

Triveni to take experimental eczema drug to the clinic, backed by new $115M financing round

7 months ago

UK biotech bags $43M in Series A to move Huntington's drug into first human study

7 months ago

First page Previous page 6 7 8910 11 12 Next page Last page